Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31/03/2025 along with the Auditors Report and Press Release is herewith attached for your perusal.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved audited financial results for Q4 and FY ended 31/03/2025. Consolidated revenue jumped 8,645% YoY to ₹7,338.59 lakhs from just ₹83.92 lakhs in FY24, while net profit rose 489% to ₹336.58 lakhs from ₹57.18 lakhs. Q4 FY25 revenue stood at ₹2,236.81 lakhs with net profit of ₹109.3 lakhs, up 548% from ₹16.85 lakhs in Q4 FY24. EPS rose to ₹0.692 (FY25) from ₹0.176 (FY24). The statutory auditor issued an unmodified (clean) opinion on both standalone and consolidated results. The board also appointed M/s. Megha Khandelwal & Associates as Secretarial Auditor for FY25 and M/s. K S G C & Associates as Internal Auditor for FY26.
Headline revenue and profit growth looks explosive, but investors should note the prior-year base was extremely small, so the absolute numbers remain modest. A clean audit opinion and expansion into preventive healthcare centers (e.g., Virar) support positive momentum, though sustainability of this growth trajectory is yet to be proven.